
Growth
CJC (no DAC)/Ipamorelin
5mg/5mg
$56.25$75.00



Front
Growth
$30.00$40.00
Strength · 5mg
Strength & vitality — single-batch, third-party verified.
Research Notice
For laboratory research use only. Not for human consumption.
The Dossier
CJC-1295 (no DAC), also known as Modified GRF(1-29), is a synthetic 29-amino-acid analog of growth-hormone-releasing hormone. It is a tetrasubstituted derivative of the GRF(1-29) sequence, modified at four positions to resist enzymatic degradation while retaining a short half-life and pulsatile signaling character.
It is a standard reference within the growth category, distinguished from the DAC-conjugated form by its lack of the albumin-binding linker.
Research Focus
Mechanism
CJC-1295 (no DAC) is a selective agonist of the GHRH receptor, a class-B G-protein-coupled receptor on anterior-pituitary somatotroph cells. Engagement activates Gs, adenylyl cyclase, cAMP, and PKA signaling associated with pulsatile growth-hormone secretion.
The four amino-acid substitutions — including the D-Ala² position — are characterized as preventing enzymatic cleavage while preserving high homology with native GHRH.
Molecular Profile
Storage & Handling
Store the lyophilized peptide at −20°C (or 2–8°C short-term). Reconstituted solution is held at 2–8°C over the medium term; avoid freeze-thaw cycles.
References
✦Every vial ships with third-party HPLC verification; certificates of analysis are available on request.
Continue Exploring